4 ms·
1. There's nothing a drug company can do to avoid/delay the release of equivalent generics. Releasing modified preparations does not lock out competitors from c
by NavinF 3y ago
1. There's nothing a drug company can do to avoid/delay the release of equivalent generics. Releasing modified preparations does not lock out competitors from copying the original preparation
2. You have no idea how drug prices work. You don't have health insurance so you should be using prices from goodrx, not the list prices at the pharmacy. Americans either have health insurance or use the cash discount. Simplifying this would be great, but drug companies are not making the massive profits that breathless journalists claim
- beloch 3y ago1. They can trickle out improvements one at a time, ensuring that there is always demand for a non-generic. 2. Perhaps you should look into how other countries regulate drug prices[1]. This is related to why residents of Florida recently pushed the FDA to allow them to buy drugs from Canada. There is a massive price difference, yet pharmaceutical companies somehow manage to make money off the Canadian market. I'd like to think the U.S. is subsidizing development costs for the rest of the world, as some big pharma executives have claimed in the past, but it's now evident that research would be easy to sustain at a lower price point. [1]https://www.canada.ca/en/patented-medicine-prices-review/services/regulatory-process.html https://www.canada.ca/en/patented-medicine-prices-review/ser...
- NavinF 3y ago1. Which drugs have trickled out improvements? 2 That's about new drugs, not generics. Generics are dirt cheap in America. Again, look at goodrx prices not the fake retail prices